Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Neurology›EDSS: Kurtzke Expanded Disability Status Scale
Process / pipelineMultiple sclerosis disability staging

EDSS: Kurtzke Expanded Disability Status Scale

Kurtzke Expanded Disability Status Scale · Also known as: Expanded Disability Status Scale

The EDSS is the most widely used clinical disability rating scale in multiple sclerosis research and practice. Developed by John Kurtzke in 1983, it provides a 0-10 ordinal scale capturing disease severity across eight neurological functional systems and functional status. The EDSS remains the primary endpoint in MS clinical trials and longitudinal cohort studies, with decades of prognostic and comparative data worldwide.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

EDSS
MDS-UPDRSMSFCNIHSSRMIBIHunt and Hess ScaleUHDRSWFNS Scale

When to use it

Mandatory for all MS clinical trials as primary or co-primary efficacy endpoint. Recommended at baseline MS diagnosis and repeated at defined intervals (6-12 months) in specialist MS clinics. Essential for patient counseling regarding natural history and prognosis. Preferred over other MS scales in research due to 40+ year track record, extensive normative data, and comparability across decades of published trials. Particularly valuable in progressive MS phenotypes where cognitive screening alone is insufficient. Not primary outcome in pediatric MS (modified versions exist); validity in other demyelinating conditions (ADEM, NMO) limited.

Strengths & limitations

Strengths
  • Decades of longitudinal prognostic data: baseline EDSS strongly predicts secondary progressive conversion and long-term ambulation status.
  • Single composite score enables rapid clinical communication and facilitates comparison across trials, countries, and eras.
  • Incorporates functional systems and ambulation weighting reflecting patient-centered priorities (walking preservation).
  • Sensitive to disease progression: capable of detecting 1-2 point changes over 1-2 years in natural history cohorts.
  • Instrument of choice in pivotal regulatory trials; extensive precedent for regulatory interpretation and approval.
  • No equipment required; applicable in any clinical setting with trained examiner.
Limitations
  • Ordinal scale properties limit parametric statistical analysis; change from EDSS 3 to 4 may not represent equivalent disability change as 6 to 7; non-linear relationship to underlying CNS pathology.
  • Heavily weight ambulation in upper disability ranges: two patients with identical pyramidal weakness but different balance may differ by 2+ EDSS points, conflating distinct neurological domains.
  • Insensitive to cognitive decline, fatigue, pain in early disease: patient may report severe cognitive slowing or pain yet score low EDSS if pyramidal/mobility function preserved.
  • Significant inter-rater variability despite training, particularly in functional systems 3-5 (brainstem, sensory, bowel/bladder require subjective interpretation).
  • Administration time 20-30 minutes; requires neurological expertise limiting applicability in primary care.
  • Does not capture disease activity (relapses, MRI lesion burden) or inflammatory biomarkers necessary for contemporary MS assessment; typically paired with imaging and biomarkers.

Frequently asked

What is the difference between EDSS and FSS?

Functional System Scores (FSS) are the individual domain scores (pyramidal 0-5, cerebellar 0-5, brainstem 0-5, sensory 0-6, bowel/bladder 0-6, visual 0-5, cerebral 0-3, other 0-5). EDSS is the composite ordinal score (0-10 in 0.5 increments) derived from the eight FSS via Kurtzke algorithm. FSS alone do not provide single comparable score; EDSS synthesis enables comparison across patients and trials. Reporting both FSS and EDSS provides detailed and comparable information.

Is EDSS valid for pediatric MS?

EDSS was developed in adults and is less sensitive to pediatric MS phenotypes, which often feature prominent cognitive/behavioral symptoms with minimal motor deficit. The Pediatric MS Functional Composite (PAFSMC) is preferred in children. EDSS can be used in older adolescents (16-18 years) with predominantly motor presentations but is not first-choice; pediatric MS specialists recommend disease-appropriate scales.

How does EDSS change define MS progression?

Confirmed Disability Progression (CDP) is defined as ≥1.0 point sustained increase in EDSS from baseline, confirmed at ≥3 months later visit. For patients with baseline EDSS ≥5.5, a ≥0.5 point increase over ≥3 months defines progression due to floor effects at high disability. Progression thresholds vary by trial design; confirm specific definition in protocol. Relapses may transiently increase EDSS; sustained progression requires stability post-relapse.

Can EDSS be assessed via telemedicine?

Partial remote assessment possible: functional systems 5 (bowel/bladder), 7 (cerebral), and 8 (other) can be screened remotely. However, pyramidal, cerebellar, brainstem, sensory, and visual assessments require in-person neurological examination for reliability. Ambulation assessment (walking 500m, 100m, etc.) requires direct observation. Fully remote EDSS scoring is not recommended for clinical decisions; use hybrid approach with in-person motor/sensory exam and remote cognitive screening.

What is clinically meaningful EDSS change?

Minimal clinically important difference (MCID) is context-dependent: 1.0 point change is generally considered clinically meaningful. However, variability in repeated EDSS assessment (test-retest reliability) is ±0.5-1.0 points in experienced examiners; change <0.5 points should be interpreted cautiously. In relapse-remitting disease, EDSS stability over 1 year despite relapses suggests effective disease-modifying therapy. In progressive MS, >1 point EDSS increase per year is associated with poor prognosis.

Sources

  1. Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444-1452. DOI: 10.1212/wnl.33.11.1444 ↗

How to cite this page

ScholarGate. (2026, June 3). Kurtzke Expanded Disability Status Scale. ScholarGate. https://scholargate.app/en/neurology/edss-multiple-sclerosis

Related methods

MDS-UPDRSMSFCNIHSSRMI

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • MDS-UPDRSNeurology↔ compare
  • MSFCNeurology↔ compare
  • NIHSSNeurology↔ compare
  • RMINeurology↔ compare
Compare side by side →

Referenced by

BIHunt and Hess ScaleMDS-UPDRSMSFCNIHSSRMIUHDRSWFNS Scale

Similar methods

MSWS-12MSFCMSQOL-54Modified Rankin ScaleDisability Rating ScaleRMINIHSSFunctional Independence Measure Scale

Related reference concepts

Multiple Sclerosis RehabilitationMultiple SclerosisMultiple SclerosisMultiple SclerosisNeurological Assessment and ExaminationFunctional Outcomes Measurement

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — EDSS (Kurtzke Expanded Disability Status Scale). Retrieved 2026-07-21 from https://scholargate.app/en/neurology/edss-multiple-sclerosis · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
John F. Kurtzke
Subfamily
Multiple sclerosis disability staging
Year
1983
Type
Clinician-rated
Related methods
MDS-UPDRSMSFCNIHSSRMI
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account